Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Electrical tumor treatment fields for non-small cell lung cancer

Número de PMA: P230042 · 2026-07-01

SolicitanteNovocure, GmbH
Fecha de decisión2026-07-01
Número PMAP230042
Código de productoSDA
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorAN

Resumen del dispositivo

Electrical tumor treatment fields for non-small cell lung cancer is the device name listed in this FDA 510(k) record. The listed applicant is Novocure, GmbH. It received FDA 510(k) clearance on 2026-07-01. The device is classified under product code SDA. It was reviewed by the AN advisory panel.

Preguntas frecuentes

What is the Electrical tumor treatment fields for non-small cell lung cancer?

Electrical tumor treatment fields for non-small cell lung cancer is a medical device that received FDA 510(k) clearance on 2026-07-01. The listed applicant is Novocure, GmbH.

When did Electrical tumor treatment fields for non-small cell lung cancer receive FDA 510(k) clearance?

The clearance date for Electrical tumor treatment fields for non-small cell lung cancer can be found in the official FDA records.

Who is the listed applicant for Electrical tumor treatment fields for non-small cell lung cancer?

The FDA 510(k) record lists Novocure, GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Electrical tumor treatment fields for non-small cell lung cancer?

The FDA product code for Electrical tumor treatment fields for non-small cell lung cancer is SDA.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑